Recent Mergers and Acquisitions
SomaLogic, Inc. acquisition by CM Life Sciences II Inc.
SomaLogic, a privately-owned protein biomarker discovery and diagnostics company, was acquired by CM Life Sciences II (NASDAQ: CMII), a special purpose acquisition company, for $651 million.
Morrow Sodali acted as the proxy solicitor for the target in this transaction.
Find more information here.